investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
PI 3-Kinase Signaling Pathways in Disease
David L Woodland
4 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
David A Fruman
University of California, Irvine
Irvine, United States
Phillip T Hawkins
Babraham Institute (BBSRC)
Cambridge, United Kingdom
David L Woodland
Keystone Symposia On Molecular and Cellular Biology
Silverthorne, United States
Lori Friedman
Genetech, Inc.
San Francisco, United States
Collaborator from Fairmont Hotel Vancouver
Fairmont Hotel Vancouver
Vancouver, Canada
Related projects
Antonio Di Cristofano
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
All cancers but non-melanoma skin cancer
Komaraiah Palle
Ras18-mediated Fanconi Anemia pathway activation in response to camptothecin
All cancers but non-melanoma skin cancer
Marc Nicklaus
HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development
All cancers but non-melanoma skin cancer
Helen Tanton
An investigation into the role of ATPase Inhibitory Factor 1 in pancreatic cancer
All cancers but non-melanoma skin cancer
Marco Marra
Exploring the relationship between the genome and the epigenome in cancers
All cancers but non-melanoma skin cancer
Benjamin Neel
CRC Tier 1 - Treatments for RASopathies and cancer
All cancers but non-melanoma skin cancer
Ira Daar
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
All cancers but non-melanoma skin cancer
Charles P. Lin
(PQC2) Localization as a determinant of cancer dormancy
All cancers but non-melanoma skin cancer
Myriam Hemberger
PARP1 is essential to maintain the epigenetic hallmarks of imprinting control regions
All cancers but non-melanoma skin cancer